Pascal Turlure

8.3k citations
201 papers · 6.7k · 2 hit papers · h-index 37

Impact in

  • Hematology top 0.2%
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation
    • Chronic Myeloid Leukemia Treatments
  • Genetics top 1%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

    • Acute Myeloid Leukemia Research 75
    • Hematopoietic Stem Cell Transplantation 48
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 10

Pascal Turlure

195 papers receiving 6.5k citations

Pascal Turlure's Hit Papers

Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial 2018 · 290 citations
2900+4+9Years since publication250500750

Peers

Pascal Turlure
Comparison fields: 5 of 89
  • Hematology 3.6k
  • Genetics 720
  • Public Health, Environmental and Occupational Health 602
  • Immunology 346
  • Oncology 306
Replace Chang‐Ki Min with:
Chang‐Ki Min South Korea
Andrzej Rafal Hellmann Poland
Christof Scheid Germany
Nicola Cascavilla Italy
Paolo N. Anderlini United States
Domenico Russo Italy
Salut Brunet Spain
Celalettin Üstün United States
Attilio Olivieri Italy
Maria Ilaria Del Principe Italy
Pascal Turlure relative to Chang‐Ki Min South Korea Chang‐Ki Min's profile →
Citations per field
00.5×2×3×3.6×
Chang‐Ki Min · 1×
Citations per year

Countries citing papers authored by Pascal Turlure

Since Specialization
Citations

This map shows the geographic impact of Pascal Turlure's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Turlure with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Turlure more than expected).

Fields of papers citing papers by Pascal Turlure

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Turlure. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Turlure. The network helps show where Pascal Turlure may publish in the future.

Co-authors

The 25 scholars most cited alongside Pascal Turlure, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pascal Turlure Line = papers co-authored together Pascal Turlure links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 201 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
Hit paper breakdown →
2012845
2 2008476
3 2010327
4
Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial
Hit paper breakdown →
2018290
5 2006252
6 1995218
7 2014206
8 2008198
9 2010194
10 2007145
11 2010134
12 2010128
13 2010119
14 2008118
15 2011107
16 2019100
17 200096
18 200694
19 200873
20 201573

About Pascal Turlure

Pascal Turlure is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Pathology and Forensic Medicine and Oncology, having authored 201 papers that have together received 6.7k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (75 papers), Hematopoietic Stem Cell Transplantation (48 papers), Acute Lymphoblastic Leukemia research (26 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers), Lymphoma Diagnosis and Treatment (9 papers), Retinoids in leukemia and cellular processes (8 papers), Inflammatory mediators and NSAID effects (6 papers) and Cytomegalovirus and herpesvirus research (5 papers). The work is most often cited by research in Hematology (3.6k citations), Genetics (720 citations), Public Health, Environmental and Occupational Health (602 citations), Immunology (346 citations) and Oncology (306 citations). Pascal Turlure has collaborated with scholars based in France, Belgium and Germany. Frequent co-authors include Sylvie Chevret, Pierre Fenaux, Hervé Dombret, Xavier Thomas, Dominique Bordessoule, Emmanuel Raffoux, Claude Gardin, Oumédaly Reman, Sylvie Castaigné and Cécile Pautas. Their work appears in journals such as Blood, Bone Marrow Transplantation, Leukemia Research, Leukemia and Haematologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact